Page last updated: 2024-12-08

1-(2'-pyridyl)benzo-1,2,3-triazole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1-(2'-pyridyl)benzo-1,2,3-triazole, also known as **PBT**, is a heterocyclic organic compound with a specific structure. It consists of a benzo-1,2,3-triazole ring system with a 2-pyridyl group attached to the nitrogen atom at position 1.

**Importance in research:**

PBT has gained significant attention in various research areas due to its unique properties and potential applications:

**1. Click Chemistry:**
- PBT is a valuable reagent in click chemistry, a powerful tool for synthesizing complex molecules by joining smaller building blocks.
- It readily undergoes a copper-catalyzed azide-alkyne cycloaddition (CuAAC) reaction with azide-containing molecules, forming stable triazole linkages.

**2. Bioconjugation:**
- Its click chemistry capabilities make PBT a versatile tool for bioconjugation, the process of attaching molecules to biological targets.
- It can be used to label proteins, antibodies, and other biomolecules with fluorescent dyes, radioactive isotopes, or other functionalities for imaging, tracking, and diagnostic purposes.

**3. Materials Science:**
- PBT can be incorporated into polymers, nanoparticles, and other materials to enhance their properties.
- Its presence can improve thermal stability, mechanical strength, and biocompatibility of materials.

**4. Drug Discovery:**
- PBT and its derivatives have shown promise as potential drug candidates.
- The triazole ring and the pyridine moiety provide structural motifs that can interact with biological targets, leading to therapeutic effects.

**5. Supramolecular Chemistry:**
- PBT's ability to form strong hydrogen bonds and other non-covalent interactions makes it suitable for constructing supramolecular assemblies, which are important in fields like self-assembly and nanotechnology.

**Overall, 1-(2'-pyridyl)benzo-1,2,3-triazole (PBT) is a versatile compound with a wide range of applications in chemistry, biology, materials science, and medicine. Its unique properties, including its click chemistry reactivity and ability to form stable triazole linkages, make it a valuable tool for research and development.**

1-(2'-pyridyl)benzo-1,2,3-triazole: RN is from 9th CI, Chem Subs Index; cpd not in Chemline 9/9/82 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID151802
CHEMBL ID1380042
SCHEMBL ID678640
MeSH IDM0053554

Synonyms (24)

Synonym
OPREA1_870601 ,
smr000037244
MLS000038150
1-(pyridin-2-yl)-1h-benzotriazole
STK059875
AKOS003671433
1-pyridin-2-ylbenzotriazole
1-(2'-pyridyl)benzo-1,2,3-triazole
13174-93-1
1h-benzotriazole, 1-(2-pyridinyl)-
HMS2166K11
FT-0674192
1-(2-pyridinyl)benzotriazole
HMS3311F20
SCHEMBL678640
1-(pyridin-2-yl)-1h-1,2,3-benzotriazole
AE-842/00014040
1-(2-pyridinyl)-1h-1,2,3-benzotriazole
CHEMBL1380042
DTXSID70157191
CPWBWUGSSFRASR-UHFFFAOYSA-N
1-(pyridin-2-yl)-1h-benzo[d][1,2,3]triazole
1-(2-pyridyl)benzotriazole
CS-0321042
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Beta-lactamaseEscherichia coli K-12Potency0.70790.044717.8581100.0000AID485294
LuciferasePhotinus pyralis (common eastern firefly)Potency37.93300.007215.758889.3584AID588342
ATAD5 protein, partialHomo sapiens (human)Potency20.59620.004110.890331.5287AID504467
P53Homo sapiens (human)Potency22.38720.07319.685831.6228AID504706
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency89.12510.354828.065989.1251AID504847
chromobox protein homolog 1Homo sapiens (human)Potency79.43280.006026.168889.1251AID540317
nuclear factor erythroid 2-related factor 2 isoform 2Homo sapiens (human)Potency29.09290.00419.984825.9290AID504444
ras-related protein Rab-9AHomo sapiens (human)Potency3.54810.00022.621531.4954AID485297
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency39.81070.050127.073689.1251AID588590
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.56 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]